Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Navelbine in Recurrent Anaplastic Large Cell Lymphoma
NCT03397953Phase 2Completed
- Sponsor
- Children's Oncology Group
- Start
- Nov 2016
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vinorelbine in anaplastic large cell lymphoma (ALCL), sponsored by Children's Oncology Group. Started Nov 2016; status: completed.
02
Drugs
vinorelbine
03
Conditions
anaplastic large cell lymphoma (ALCL)
Beyond the preview
Go deeper on NCT03397953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03397953.